nodes	percent_of_prediction	percent_of_DWPC	metapath
Calcitriol—CYP3A4—Topotecan—ovarian cancer	0.0353	0.354	CbGbCtD
Calcitriol—CYP3A4—Vinorelbine—ovarian cancer	0.0248	0.249	CbGbCtD
Calcitriol—CYP3A4—Paclitaxel—ovarian cancer	0.0175	0.175	CbGbCtD
Calcitriol—CYP24A1—endometrium—ovarian cancer	0.0129	0.119	CbGeAlD
Calcitriol—GC—female reproductive system—ovarian cancer	0.0128	0.119	CbGeAlD
Calcitriol—VDR—Ovarian Infertility Genes—NR5A1—ovarian cancer	0.0127	0.0546	CbGpPWpGaD
Calcitriol—CYP3A4—Docetaxel—ovarian cancer	0.0126	0.127	CbGbCtD
Calcitriol—VDR—Ovarian Infertility Genes—INHA—ovarian cancer	0.0124	0.0531	CbGpPWpGaD
Calcitriol—VDR—Nuclear Receptors—NR5A1—ovarian cancer	0.0111	0.0476	CbGpPWpGaD
Calcitriol—CYP24A1—female reproductive system—ovarian cancer	0.0107	0.0988	CbGeAlD
Calcitriol—CYP24A1—vagina—ovarian cancer	0.00964	0.0893	CbGeAlD
Calcitriol—CYP3A4—Doxorubicin—ovarian cancer	0.00941	0.0945	CbGbCtD
Calcitriol—VDR—Nuclear Receptor transcription pathway—NR5A1—ovarian cancer	0.00878	0.0376	CbGpPWpGaD
Calcitriol—VDR—epithelium—ovarian cancer	0.0079	0.0732	CbGeAlD
Calcitriol—VDR—uterine cervix—ovarian cancer	0.00784	0.0726	CbGeAlD
Calcitriol—VDR—decidua—ovarian cancer	0.00747	0.0692	CbGeAlD
Calcitriol—VDR—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	0.00737	0.0316	CbGpPWpGaD
Calcitriol—VDR—Ovarian Infertility Genes—MLH1—ovarian cancer	0.00669	0.0287	CbGpPWpGaD
Calcitriol—VDR—uterus—ovarian cancer	0.00653	0.0605	CbGeAlD
Calcitriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—TP63—ovarian cancer	0.00649	0.0278	CbGpPWpGaD
Calcitriol—VDR—Ovarian Infertility Genes—PGR—ovarian cancer	0.00635	0.0272	CbGpPWpGaD
Calcitriol—VDR—female reproductive system—ovarian cancer	0.00587	0.0544	CbGeAlD
Calcitriol—VDR—Validated transcriptional targets of TAp63 isoforms—TP63—ovarian cancer	0.00581	0.0249	CbGpPWpGaD
Calcitriol—VDR—bone marrow—ovarian cancer	0.00554	0.0514	CbGeAlD
Calcitriol—VDR—Nuclear Receptors—PGR—ovarian cancer	0.00553	0.0237	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—YAP1—ovarian cancer	0.00534	0.0229	CbGpPWpGaD
Calcitriol—VDR—female gonad—ovarian cancer	0.00534	0.0495	CbGeAlD
Calcitriol—VDR—vagina—ovarian cancer	0.00531	0.0492	CbGeAlD
Calcitriol—VDR—Ovarian Infertility Genes—CCND2—ovarian cancer	0.00507	0.0217	CbGpPWpGaD
Calcitriol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.00505	0.0216	CbGpPWpGaD
Calcitriol—VDR—testis—ovarian cancer	0.00474	0.0439	CbGeAlD
Calcitriol—VDR—Direct p53 effectors—CD82—ovarian cancer	0.00467	0.02	CbGpPWpGaD
Calcitriol—VDR—Nuclear Receptor transcription pathway—PGR—ovarian cancer	0.00437	0.0187	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—FASN—ovarian cancer	0.00436	0.0187	CbGpPWpGaD
Calcitriol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.00423	0.0181	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of TAp63 isoforms—GADD45A—ovarian cancer	0.0039	0.0167	CbGpPWpGaD
Calcitriol—CYP24A1—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.00389	0.0167	CbGpPWpGaD
Calcitriol—CYP24A1—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.00384	0.0165	CbGpPWpGaD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—ATF3—ovarian cancer	0.00351	0.015	CbGpPWpGaD
Calcitriol—VDR—lymph node—ovarian cancer	0.00344	0.0318	CbGeAlD
Calcitriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—ovarian cancer	0.00337	0.0144	CbGpPWpGaD
Calcitriol—CYP24A1—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.00316	0.0135	CbGpPWpGaD
Calcitriol—VDR—Nuclear Receptors—ESR1—ovarian cancer	0.00295	0.0126	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—TP63—ovarian cancer	0.00271	0.0116	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.00242	0.0104	CbGpPWpGaD
Calcitriol—VDR—Nuclear Receptor transcription pathway—ESR1—ovarian cancer	0.00233	0.01	CbGpPWpGaD
Calcitriol—CYP3A4—Liver X Receptor Pathway—FASN—ovarian cancer	0.00233	0.00996	CbGpPWpGaD
Calcitriol—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—ovarian cancer	0.00231	0.00987	CbGpPWpGaD
Calcitriol—VDR—Ovarian Infertility Genes—CDKN1B—ovarian cancer	0.0023	0.00986	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—MSH2—ovarian cancer	0.00228	0.00977	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—ATF3—ovarian cancer	0.00226	0.0097	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—SMARCA4—ovarian cancer	0.00213	0.00912	CbGpPWpGaD
Calcitriol—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ovarian cancer	0.00209	0.00893	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—MLH1—ovarian cancer	0.00206	0.0088	CbGpPWpGaD
Calcitriol—CYP3A4—female reproductive system—ovarian cancer	0.00196	0.0182	CbGeAlD
Calcitriol—GC—Metabolism—NME2—ovarian cancer	0.00191	0.0082	CbGpPWpGaD
Calcitriol—VDR—Retinoic acid receptors-mediated signaling—MAPK3—ovarian cancer	0.00191	0.00817	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—GADD45A—ovarian cancer	0.00182	0.00779	CbGpPWpGaD
Calcitriol—VDR—Retinoic acid receptors-mediated signaling—MAPK1—ovarian cancer	0.00182	0.00778	CbGpPWpGaD
Calcitriol—Skin disorder—Topotecan—ovarian cancer	0.00169	0.00303	CcSEcCtD
Calcitriol—Bone pain—Epirubicin—ovarian cancer	0.00168	0.003	CcSEcCtD
Calcitriol—CYP24A1—Biological oxidations—CYP1B1—ovarian cancer	0.00168	0.00718	CbGpPWpGaD
Calcitriol—Pain—Chlorambucil—ovarian cancer	0.00168	0.003	CcSEcCtD
Calcitriol—Anorexia—Topotecan—ovarian cancer	0.00166	0.00297	CcSEcCtD
Calcitriol—Skin disorder—Melphalan—ovarian cancer	0.00166	0.00297	CcSEcCtD
Calcitriol—CYP24A1—Metapathway biotransformation—CYP1B1—ovarian cancer	0.00165	0.00708	CbGpPWpGaD
Calcitriol—Anorexia—Melphalan—ovarian cancer	0.00163	0.00291	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.00162	0.00696	CbGpPWpGaD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—ESR1—ovarian cancer	0.00161	0.0069	CbGpPWpGaD
Calcitriol—Dehydration—Docetaxel—ovarian cancer	0.00161	0.00288	CcSEcCtD
Calcitriol—Phosphatase alkaline increased—Epirubicin—ovarian cancer	0.00161	0.00288	CcSEcCtD
Calcitriol—Nocturia—Doxorubicin—ovarian cancer	0.0016	0.00287	CcSEcCtD
Calcitriol—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.0016	0.00287	CcSEcCtD
Calcitriol—Weight decreased—Paclitaxel—ovarian cancer	0.0016	0.00286	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00159	0.00284	CcSEcCtD
Calcitriol—Abdominal pain upper—Docetaxel—ovarian cancer	0.00158	0.00283	CcSEcCtD
Calcitriol—Hypertension—Vinorelbine—ovarian cancer	0.00158	0.00282	CcSEcCtD
Calcitriol—Aspartate aminotransferase increased—Docetaxel—ovarian cancer	0.00156	0.00279	CcSEcCtD
Calcitriol—Urticaria—Chlorambucil—ovarian cancer	0.00156	0.00278	CcSEcCtD
Calcitriol—Myalgia—Vinorelbine—ovarian cancer	0.00156	0.00278	CcSEcCtD
Calcitriol—Chest pain—Vinorelbine—ovarian cancer	0.00156	0.00278	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.00156	0.00278	CcSEcCtD
Calcitriol—Bone pain—Doxorubicin—ovarian cancer	0.00155	0.00278	CcSEcCtD
Calcitriol—Abdominal pain—Chlorambucil—ovarian cancer	0.00155	0.00277	CcSEcCtD
Calcitriol—Body temperature increased—Chlorambucil—ovarian cancer	0.00155	0.00277	CcSEcCtD
Calcitriol—Nasopharyngitis—Docetaxel—ovarian cancer	0.00155	0.00277	CcSEcCtD
Calcitriol—Discomfort—Vinorelbine—ovarian cancer	0.00154	0.00275	CcSEcCtD
Calcitriol—Urinary tract infection—Paclitaxel—ovarian cancer	0.00153	0.00274	CcSEcCtD
Calcitriol—Conjunctivitis—Paclitaxel—ovarian cancer	0.00153	0.00274	CcSEcCtD
Calcitriol—Blood urea increased—Epirubicin—ovarian cancer	0.00152	0.00272	CcSEcCtD
Calcitriol—Decreased appetite—Topotecan—ovarian cancer	0.00152	0.00271	CcSEcCtD
Calcitriol—VDR—Generic Transcription Pathway—NR5A1—ovarian cancer	0.00152	0.00649	CbGpPWpGaD
Calcitriol—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00149	0.00267	CcSEcCtD
Calcitriol—Pain—Topotecan—ovarian cancer	0.00149	0.00267	CcSEcCtD
Calcitriol—Constipation—Topotecan—ovarian cancer	0.00149	0.00267	CcSEcCtD
Calcitriol—Phosphatase alkaline increased—Doxorubicin—ovarian cancer	0.00149	0.00266	CcSEcCtD
Calcitriol—Decreased appetite—Melphalan—ovarian cancer	0.00148	0.00266	CcSEcCtD
Calcitriol—Pain—Melphalan—ovarian cancer	0.00146	0.00261	CcSEcCtD
Calcitriol—Skin disorder—Vinorelbine—ovarian cancer	0.00145	0.00259	CcSEcCtD
Calcitriol—Hypersensitivity—Chlorambucil—ovarian cancer	0.00144	0.00258	CcSEcCtD
Calcitriol—Gastrointestinal pain—Topotecan—ovarian cancer	0.00143	0.00255	CcSEcCtD
Calcitriol—Anorexia—Vinorelbine—ovarian cancer	0.00142	0.00254	CcSEcCtD
Calcitriol—Haemoglobin—Paclitaxel—ovarian cancer	0.00142	0.00254	CcSEcCtD
Calcitriol—Haemorrhage—Paclitaxel—ovarian cancer	0.00141	0.00253	CcSEcCtD
Calcitriol—Asthenia—Chlorambucil—ovarian cancer	0.00141	0.00251	CcSEcCtD
Calcitriol—Blood urea increased—Doxorubicin—ovarian cancer	0.0014	0.00251	CcSEcCtD
Calcitriol—Pruritus—Chlorambucil—ovarian cancer	0.00139	0.00248	CcSEcCtD
Calcitriol—Urticaria—Topotecan—ovarian cancer	0.00139	0.00248	CcSEcCtD
Calcitriol—Body temperature increased—Topotecan—ovarian cancer	0.00138	0.00247	CcSEcCtD
Calcitriol—Abdominal pain—Topotecan—ovarian cancer	0.00138	0.00247	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00136	0.00243	CcSEcCtD
Calcitriol—Urticaria—Melphalan—ovarian cancer	0.00136	0.00243	CcSEcCtD
Calcitriol—Weight decreased—Docetaxel—ovarian cancer	0.00135	0.00242	CcSEcCtD
Calcitriol—Blood alkaline phosphatase increased—Epirubicin—ovarian cancer	0.00134	0.0024	CcSEcCtD
Calcitriol—Diarrhoea—Chlorambucil—ovarian cancer	0.00134	0.0024	CcSEcCtD
Calcitriol—Erythema multiforme—Paclitaxel—ovarian cancer	0.00134	0.00239	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.00132	0.00567	CbGpPWpGaD
Calcitriol—CYP3A4—Estrogen metabolism—CYP1B1—ovarian cancer	0.00132	0.00567	CbGpPWpGaD
Calcitriol—Decreased appetite—Vinorelbine—ovarian cancer	0.0013	0.00232	CcSEcCtD
Calcitriol—Conjunctivitis—Docetaxel—ovarian cancer	0.0013	0.00232	CcSEcCtD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.00129	0.00554	CbGpPWpGaD
Calcitriol—VDR—Retinoic acid receptors-mediated signaling—AKT1—ovarian cancer	0.00129	0.00551	CbGpPWpGaD
Calcitriol—Hypersensitivity—Topotecan—ovarian cancer	0.00128	0.0023	CcSEcCtD
Calcitriol—Constipation—Vinorelbine—ovarian cancer	0.00128	0.00228	CcSEcCtD
Calcitriol—Pain—Vinorelbine—ovarian cancer	0.00128	0.00228	CcSEcCtD
Calcitriol—Arrhythmia—Paclitaxel—ovarian cancer	0.00126	0.00226	CcSEcCtD
Calcitriol—Hypersensitivity—Melphalan—ovarian cancer	0.00126	0.00225	CcSEcCtD
Calcitriol—Asthenia—Topotecan—ovarian cancer	0.00125	0.00224	CcSEcCtD
Calcitriol—Vomiting—Chlorambucil—ovarian cancer	0.00125	0.00223	CcSEcCtD
Calcitriol—Blood alkaline phosphatase increased—Doxorubicin—ovarian cancer	0.00124	0.00222	CcSEcCtD
Calcitriol—Pruritus—Topotecan—ovarian cancer	0.00123	0.00221	CcSEcCtD
Calcitriol—GC—Metabolism—CYTB—ovarian cancer	0.00123	0.00528	CbGpPWpGaD
Calcitriol—Erythema—Paclitaxel—ovarian cancer	0.00123	0.0022	CcSEcCtD
Calcitriol—Asthenia—Melphalan—ovarian cancer	0.00123	0.00219	CcSEcCtD
Calcitriol—Dermatitis bullous—Epirubicin—ovarian cancer	0.00122	0.00219	CcSEcCtD
Calcitriol—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00122	0.00218	CcSEcCtD
Calcitriol—Pruritus—Melphalan—ovarian cancer	0.00121	0.00216	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.00121	0.00517	CbGpPWpGaD
Calcitriol—Dysgeusia—Paclitaxel—ovarian cancer	0.0012	0.00215	CcSEcCtD
Calcitriol—Haemoglobin—Docetaxel—ovarian cancer	0.0012	0.00215	CcSEcCtD
Calcitriol—Haemorrhage—Docetaxel—ovarian cancer	0.0012	0.00214	CcSEcCtD
Calcitriol—Diarrhoea—Topotecan—ovarian cancer	0.00119	0.00213	CcSEcCtD
Calcitriol—Urticaria—Vinorelbine—ovarian cancer	0.00119	0.00212	CcSEcCtD
Calcitriol—Abdominal pain—Vinorelbine—ovarian cancer	0.00118	0.00211	CcSEcCtD
Calcitriol—Body temperature increased—Vinorelbine—ovarian cancer	0.00118	0.00211	CcSEcCtD
Calcitriol—CYP3A4—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.00117	0.00501	CbGpPWpGaD
Calcitriol—Diarrhoea—Melphalan—ovarian cancer	0.00117	0.00209	CcSEcCtD
Calcitriol—Pain in extremity—Epirubicin—ovarian cancer	0.00117	0.00209	CcSEcCtD
Calcitriol—Nausea—Chlorambucil—ovarian cancer	0.00116	0.00208	CcSEcCtD
Calcitriol—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	0.00114	0.00489	CbGpPWpGaD
Calcitriol—Erythema multiforme—Docetaxel—ovarian cancer	0.00113	0.00203	CcSEcCtD
Calcitriol—Dermatitis bullous—Doxorubicin—ovarian cancer	0.00113	0.00202	CcSEcCtD
Calcitriol—Agitation—Paclitaxel—ovarian cancer	0.00113	0.00202	CcSEcCtD
Calcitriol—Vomiting—Topotecan—ovarian cancer	0.00111	0.00198	CcSEcCtD
Calcitriol—Rash—Topotecan—ovarian cancer	0.0011	0.00197	CcSEcCtD
Calcitriol—Hypersensitivity—Vinorelbine—ovarian cancer	0.0011	0.00197	CcSEcCtD
Calcitriol—Dermatitis—Topotecan—ovarian cancer	0.0011	0.00197	CcSEcCtD
Calcitriol—Blood creatinine increased—Epirubicin—ovarian cancer	0.00109	0.00196	CcSEcCtD
Calcitriol—Headache—Topotecan—ovarian cancer	0.00109	0.00195	CcSEcCtD
Calcitriol—Vomiting—Melphalan—ovarian cancer	0.00109	0.00194	CcSEcCtD
Calcitriol—Dehydration—Epirubicin—ovarian cancer	0.00109	0.00194	CcSEcCtD
Calcitriol—Pain in extremity—Doxorubicin—ovarian cancer	0.00108	0.00193	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—CAV1—ovarian cancer	0.00108	0.00462	CbGpPWpGaD
Calcitriol—GC—Metabolism—PPP1CC—ovarian cancer	0.00108	0.00462	CbGpPWpGaD
Calcitriol—GC—Metabolism—BRIP1—ovarian cancer	0.00108	0.00462	CbGpPWpGaD
Calcitriol—Rash—Melphalan—ovarian cancer	0.00108	0.00193	CcSEcCtD
Calcitriol—Dermatitis—Melphalan—ovarian cancer	0.00108	0.00192	CcSEcCtD
Calcitriol—Asthenia—Vinorelbine—ovarian cancer	0.00107	0.00192	CcSEcCtD
Calcitriol—Arrhythmia—Docetaxel—ovarian cancer	0.00107	0.00191	CcSEcCtD
Calcitriol—Abdominal pain upper—Epirubicin—ovarian cancer	0.00107	0.00191	CcSEcCtD
Calcitriol—Convulsion—Paclitaxel—ovarian cancer	0.00107	0.00191	CcSEcCtD
Calcitriol—Hypertension—Paclitaxel—ovarian cancer	0.00106	0.0019	CcSEcCtD
Calcitriol—Pruritus—Vinorelbine—ovarian cancer	0.00106	0.00189	CcSEcCtD
Calcitriol—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.00105	0.00188	CcSEcCtD
Calcitriol—Myalgia—Paclitaxel—ovarian cancer	0.00105	0.00187	CcSEcCtD
Calcitriol—Chest pain—Paclitaxel—ovarian cancer	0.00105	0.00187	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—MET—ovarian cancer	0.00104	0.00447	CbGpPWpGaD
Calcitriol—Nasopharyngitis—Epirubicin—ovarian cancer	0.00104	0.00187	CcSEcCtD
Calcitriol—Anxiety—Paclitaxel—ovarian cancer	0.00104	0.00187	CcSEcCtD
Calcitriol—Erythema—Docetaxel—ovarian cancer	0.00104	0.00186	CcSEcCtD
Calcitriol—Nausea—Topotecan—ovarian cancer	0.00104	0.00185	CcSEcCtD
Calcitriol—Discomfort—Paclitaxel—ovarian cancer	0.00103	0.00185	CcSEcCtD
Calcitriol—VDR—Gene Expression—WDR77—ovarian cancer	0.00102	0.00439	CbGpPWpGaD
Calcitriol—Dry mouth—Paclitaxel—ovarian cancer	0.00102	0.00183	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—NME2—ovarian cancer	0.00102	0.00438	CbGpPWpGaD
Calcitriol—Diarrhoea—Vinorelbine—ovarian cancer	0.00102	0.00183	CcSEcCtD
Calcitriol—Dysgeusia—Docetaxel—ovarian cancer	0.00102	0.00183	CcSEcCtD
Calcitriol—Nausea—Melphalan—ovarian cancer	0.00101	0.00181	CcSEcCtD
Calcitriol—Blood creatinine increased—Doxorubicin—ovarian cancer	0.00101	0.00181	CcSEcCtD
Calcitriol—Dehydration—Doxorubicin—ovarian cancer	0.001	0.0018	CcSEcCtD
Calcitriol—Anaphylactic shock—Paclitaxel—ovarian cancer	0.001	0.0018	CcSEcCtD
Calcitriol—Pancreatitis—Epirubicin—ovarian cancer	0.000989	0.00177	CcSEcCtD
Calcitriol—Abdominal pain upper—Doxorubicin—ovarian cancer	0.000986	0.00176	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—APC—ovarian cancer	0.000984	0.00421	CbGpPWpGaD
Calcitriol—Skin disorder—Paclitaxel—ovarian cancer	0.000975	0.00174	CcSEcCtD
Calcitriol—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000973	0.00174	CcSEcCtD
Calcitriol—Nasopharyngitis—Doxorubicin—ovarian cancer	0.000966	0.00173	CcSEcCtD
Calcitriol—CYP3A4—Irinotecan Pathway—APC—ovarian cancer	0.000961	0.00412	CbGpPWpGaD
Calcitriol—Anorexia—Paclitaxel—ovarian cancer	0.000957	0.00171	CcSEcCtD
Calcitriol—Vomiting—Vinorelbine—ovarian cancer	0.000949	0.0017	CcSEcCtD
Calcitriol—Rash—Vinorelbine—ovarian cancer	0.000941	0.00168	CcSEcCtD
Calcitriol—Dermatitis—Vinorelbine—ovarian cancer	0.00094	0.00168	CcSEcCtD
Calcitriol—Headache—Vinorelbine—ovarian cancer	0.000935	0.00167	CcSEcCtD
Calcitriol—Pancreatitis—Doxorubicin—ovarian cancer	0.000915	0.00164	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000914	0.00164	CcSEcCtD
Calcitriol—Weight decreased—Epirubicin—ovarian cancer	0.000913	0.00163	CcSEcCtD
Calcitriol—Insomnia—Paclitaxel—ovarian cancer	0.000908	0.00162	CcSEcCtD
Calcitriol—Convulsion—Docetaxel—ovarian cancer	0.000903	0.00162	CcSEcCtD
Calcitriol—Hypertension—Docetaxel—ovarian cancer	0.0009	0.00161	CcSEcCtD
Calcitriol—Drowsiness—Epirubicin—ovarian cancer	0.0009	0.00161	CcSEcCtD
Calcitriol—Somnolence—Paclitaxel—ovarian cancer	0.000892	0.0016	CcSEcCtD
Calcitriol—Myalgia—Docetaxel—ovarian cancer	0.000887	0.00159	CcSEcCtD
Calcitriol—Chest pain—Docetaxel—ovarian cancer	0.000887	0.00159	CcSEcCtD
Calcitriol—Nausea—Vinorelbine—ovarian cancer	0.000886	0.00159	CcSEcCtD
Calcitriol—Conjunctivitis—Epirubicin—ovarian cancer	0.000874	0.00156	CcSEcCtD
Calcitriol—Urinary tract infection—Epirubicin—ovarian cancer	0.000874	0.00156	CcSEcCtD
Calcitriol—Decreased appetite—Paclitaxel—ovarian cancer	0.000872	0.00156	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—MMP2—ovarian cancer	0.000872	0.00373	CbGpPWpGaD
Calcitriol—Dry mouth—Docetaxel—ovarian cancer	0.000868	0.00155	CcSEcCtD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000867	0.00371	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—YAP1—ovarian cancer	0.000865	0.0037	CbGpPWpGaD
Calcitriol—Constipation—Paclitaxel—ovarian cancer	0.000858	0.00154	CcSEcCtD
Calcitriol—Pain—Paclitaxel—ovarian cancer	0.000858	0.00154	CcSEcCtD
Calcitriol—Anaphylactic shock—Docetaxel—ovarian cancer	0.000851	0.00152	CcSEcCtD
Calcitriol—Weight decreased—Doxorubicin—ovarian cancer	0.000845	0.00151	CcSEcCtD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—MYC—ovarian cancer	0.000838	0.00359	CbGpPWpGaD
Calcitriol—Drowsiness—Doxorubicin—ovarian cancer	0.000832	0.00149	CcSEcCtD
Calcitriol—Skin disorder—Docetaxel—ovarian cancer	0.000826	0.00148	CcSEcCtD
Calcitriol—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000821	0.00147	CcSEcCtD
Calcitriol—Haemoglobin—Epirubicin—ovarian cancer	0.000812	0.00145	CcSEcCtD
Calcitriol—Anorexia—Docetaxel—ovarian cancer	0.000811	0.00145	CcSEcCtD
Calcitriol—Conjunctivitis—Doxorubicin—ovarian cancer	0.000809	0.00145	CcSEcCtD
Calcitriol—Urinary tract infection—Doxorubicin—ovarian cancer	0.000809	0.00145	CcSEcCtD
Calcitriol—Haemorrhage—Epirubicin—ovarian cancer	0.000808	0.00144	CcSEcCtD
Calcitriol—VDR—Gene Expression—TTF1—ovarian cancer	0.000804	0.00344	CbGpPWpGaD
Calcitriol—Urticaria—Paclitaxel—ovarian cancer	0.000797	0.00143	CcSEcCtD
Calcitriol—Body temperature increased—Paclitaxel—ovarian cancer	0.000793	0.00142	CcSEcCtD
Calcitriol—Abdominal pain—Paclitaxel—ovarian cancer	0.000793	0.00142	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000786	0.00337	CbGpPWpGaD
Calcitriol—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000775	0.00139	CcSEcCtD
Calcitriol—Insomnia—Docetaxel—ovarian cancer	0.000769	0.00138	CcSEcCtD
Calcitriol—Erythema multiforme—Epirubicin—ovarian cancer	0.000764	0.00137	CcSEcCtD
Calcitriol—Somnolence—Docetaxel—ovarian cancer	0.000756	0.00135	CcSEcCtD
Calcitriol—VDR—Generic Transcription Pathway—PGR—ovarian cancer	0.000755	0.00323	CbGpPWpGaD
Calcitriol—Haemoglobin—Doxorubicin—ovarian cancer	0.000751	0.00134	CcSEcCtD
Calcitriol—Haemorrhage—Doxorubicin—ovarian cancer	0.000747	0.00134	CcSEcCtD
Calcitriol—Decreased appetite—Docetaxel—ovarian cancer	0.000739	0.00132	CcSEcCtD
Calcitriol—Hypersensitivity—Paclitaxel—ovarian cancer	0.000739	0.00132	CcSEcCtD
Calcitriol—VDR—Gene Expression—NR5A1—ovarian cancer	0.00073	0.00313	CbGpPWpGaD
Calcitriol—Pain—Docetaxel—ovarian cancer	0.000727	0.0013	CcSEcCtD
Calcitriol—Constipation—Docetaxel—ovarian cancer	0.000727	0.0013	CcSEcCtD
Calcitriol—GC—Metabolism—YAP1—ovarian cancer	0.000723	0.0031	CbGpPWpGaD
Calcitriol—Arrhythmia—Epirubicin—ovarian cancer	0.000721	0.00129	CcSEcCtD
Calcitriol—Asthenia—Paclitaxel—ovarian cancer	0.00072	0.00129	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000716	0.00307	CbGpPWpGaD
Calcitriol—Pruritus—Paclitaxel—ovarian cancer	0.00071	0.00127	CcSEcCtD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000707	0.00303	CbGpPWpGaD
Calcitriol—Erythema multiforme—Doxorubicin—ovarian cancer	0.000706	0.00126	CcSEcCtD
Calcitriol—Erythema—Epirubicin—ovarian cancer	0.000703	0.00126	CcSEcCtD
Calcitriol—VDR—Generic Transcription Pathway—PARP1—ovarian cancer	0.000702	0.00301	CbGpPWpGaD
Calcitriol—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000696	0.00124	CcSEcCtD
Calcitriol—Dysgeusia—Epirubicin—ovarian cancer	0.000688	0.00123	CcSEcCtD
Calcitriol—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.000688	0.00295	CbGpPWpGaD
Calcitriol—Diarrhoea—Paclitaxel—ovarian cancer	0.000687	0.00123	CcSEcCtD
Calcitriol—Abdominal pain—Docetaxel—ovarian cancer	0.000672	0.0012	CcSEcCtD
Calcitriol—Body temperature increased—Docetaxel—ovarian cancer	0.000672	0.0012	CcSEcCtD
Calcitriol—Arrhythmia—Doxorubicin—ovarian cancer	0.000668	0.00119	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—CYTB—ovarian cancer	0.000659	0.00282	CbGpPWpGaD
Calcitriol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000656	0.00281	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—PTEN—ovarian cancer	0.000651	0.00279	CbGpPWpGaD
Calcitriol—Erythema—Doxorubicin—ovarian cancer	0.00065	0.00116	CcSEcCtD
Calcitriol—Agitation—Epirubicin—ovarian cancer	0.000646	0.00116	CcSEcCtD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000644	0.00276	CbGpPWpGaD
Calcitriol—Vomiting—Paclitaxel—ovarian cancer	0.000638	0.00114	CcSEcCtD
Calcitriol—Dysgeusia—Doxorubicin—ovarian cancer	0.000637	0.00114	CcSEcCtD
Calcitriol—Rash—Paclitaxel—ovarian cancer	0.000633	0.00113	CcSEcCtD
Calcitriol—Dermatitis—Paclitaxel—ovarian cancer	0.000632	0.00113	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000629	0.0027	CbGpPWpGaD
Calcitriol—Headache—Paclitaxel—ovarian cancer	0.000629	0.00112	CcSEcCtD
Calcitriol—Hypersensitivity—Docetaxel—ovarian cancer	0.000627	0.00112	CcSEcCtD
Calcitriol—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	0.000625	0.00268	CbGpPWpGaD
Calcitriol—Asthenia—Docetaxel—ovarian cancer	0.00061	0.00109	CcSEcCtD
Calcitriol—Convulsion—Epirubicin—ovarian cancer	0.000609	0.00109	CcSEcCtD
Calcitriol—Hypertension—Epirubicin—ovarian cancer	0.000607	0.00109	CcSEcCtD
Calcitriol—Pruritus—Docetaxel—ovarian cancer	0.000602	0.00108	CcSEcCtD
Calcitriol—Myalgia—Epirubicin—ovarian cancer	0.000598	0.00107	CcSEcCtD
Calcitriol—Chest pain—Epirubicin—ovarian cancer	0.000598	0.00107	CcSEcCtD
Calcitriol—Agitation—Doxorubicin—ovarian cancer	0.000598	0.00107	CcSEcCtD
Calcitriol—Anxiety—Epirubicin—ovarian cancer	0.000596	0.00107	CcSEcCtD
Calcitriol—Nausea—Paclitaxel—ovarian cancer	0.000596	0.00107	CcSEcCtD
Calcitriol—Discomfort—Epirubicin—ovarian cancer	0.000591	0.00106	CcSEcCtD
Calcitriol—GC—Metabolism—FASN—ovarian cancer	0.00059	0.00253	CbGpPWpGaD
Calcitriol—Dry mouth—Epirubicin—ovarian cancer	0.000585	0.00105	CcSEcCtD
Calcitriol—Diarrhoea—Docetaxel—ovarian cancer	0.000582	0.00104	CcSEcCtD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—AKT1—ovarian cancer	0.000581	0.00249	CbGpPWpGaD
Calcitriol—GC—Metabolism—SLC5A5—ovarian cancer	0.00058	0.00248	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PPP1CC—ovarian cancer	0.000576	0.00247	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—BRIP1—ovarian cancer	0.000576	0.00247	CbGpPWpGaD
Calcitriol—Anaphylactic shock—Epirubicin—ovarian cancer	0.000574	0.00103	CcSEcCtD
Calcitriol—Convulsion—Doxorubicin—ovarian cancer	0.000564	0.00101	CcSEcCtD
Calcitriol—Hypertension—Doxorubicin—ovarian cancer	0.000562	0.001	CcSEcCtD
Calcitriol—GC—Metabolism—SLC2A1—ovarian cancer	0.00056	0.0024	CbGpPWpGaD
Calcitriol—Skin disorder—Epirubicin—ovarian cancer	0.000557	0.000997	CcSEcCtD
Calcitriol—Chest pain—Doxorubicin—ovarian cancer	0.000554	0.000991	CcSEcCtD
Calcitriol—Myalgia—Doxorubicin—ovarian cancer	0.000554	0.000991	CcSEcCtD
Calcitriol—Anxiety—Doxorubicin—ovarian cancer	0.000552	0.000987	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000549	0.00235	CbGpPWpGaD
Calcitriol—Discomfort—Doxorubicin—ovarian cancer	0.000547	0.000979	CcSEcCtD
Calcitriol—Anorexia—Epirubicin—ovarian cancer	0.000547	0.000978	CcSEcCtD
Calcitriol—Dry mouth—Doxorubicin—ovarian cancer	0.000542	0.000969	CcSEcCtD
Calcitriol—Vomiting—Docetaxel—ovarian cancer	0.000541	0.000968	CcSEcCtD
Calcitriol—GC—Metabolism—CYP1B1—ovarian cancer	0.000537	0.0023	CbGpPWpGaD
Calcitriol—Rash—Docetaxel—ovarian cancer	0.000536	0.000959	CcSEcCtD
Calcitriol—Dermatitis—Docetaxel—ovarian cancer	0.000536	0.000959	CcSEcCtD
Calcitriol—Headache—Docetaxel—ovarian cancer	0.000533	0.000953	CcSEcCtD
Calcitriol—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000531	0.00095	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—EGFR—ovarian cancer	0.000529	0.00227	CbGpPWpGaD
Calcitriol—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000523	0.000935	CcSEcCtD
Calcitriol—Insomnia—Epirubicin—ovarian cancer	0.000519	0.000928	CcSEcCtD
Calcitriol—Skin disorder—Doxorubicin—ovarian cancer	0.000516	0.000922	CcSEcCtD
Calcitriol—Somnolence—Epirubicin—ovarian cancer	0.00051	0.000912	CcSEcCtD
Calcitriol—Anorexia—Doxorubicin—ovarian cancer	0.000506	0.000905	CcSEcCtD
Calcitriol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000505	0.00216	CbGpPWpGaD
Calcitriol—Nausea—Docetaxel—ovarian cancer	0.000505	0.000904	CcSEcCtD
Calcitriol—Decreased appetite—Epirubicin—ovarian cancer	0.000499	0.000892	CcSEcCtD
Calcitriol—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000499	0.00214	CbGpPWpGaD
Calcitriol—Constipation—Epirubicin—ovarian cancer	0.000491	0.000878	CcSEcCtD
Calcitriol—Pain—Epirubicin—ovarian cancer	0.000491	0.000878	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000484	0.000865	CcSEcCtD
Calcitriol—Insomnia—Doxorubicin—ovarian cancer	0.00048	0.000859	CcSEcCtD
Calcitriol—GC—Metabolism—PPP2R1A—ovarian cancer	0.000476	0.00204	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.000474	0.00203	CbGpPWpGaD
Calcitriol—Somnolence—Doxorubicin—ovarian cancer	0.000472	0.000844	CcSEcCtD
Calcitriol—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000469	0.000839	CcSEcCtD
Calcitriol—Decreased appetite—Doxorubicin—ovarian cancer	0.000461	0.000826	CcSEcCtD
Calcitriol—Urticaria—Epirubicin—ovarian cancer	0.000456	0.000815	CcSEcCtD
Calcitriol—Constipation—Doxorubicin—ovarian cancer	0.000454	0.000812	CcSEcCtD
Calcitriol—Pain—Doxorubicin—ovarian cancer	0.000454	0.000812	CcSEcCtD
Calcitriol—Body temperature increased—Epirubicin—ovarian cancer	0.000454	0.000811	CcSEcCtD
Calcitriol—Abdominal pain—Epirubicin—ovarian cancer	0.000454	0.000811	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—TP53—ovarian cancer	0.000444	0.0019	CbGpPWpGaD
Calcitriol—GC—Metabolism—ABCB1—ovarian cancer	0.000442	0.00189	CbGpPWpGaD
Calcitriol—GC—Metabolism—TYMS—ovarian cancer	0.000434	0.00186	CbGpPWpGaD
Calcitriol—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000434	0.000777	CcSEcCtD
Calcitriol—Hypersensitivity—Epirubicin—ovarian cancer	0.000423	0.000756	CcSEcCtD
Calcitriol—Urticaria—Doxorubicin—ovarian cancer	0.000422	0.000754	CcSEcCtD
Calcitriol—Body temperature increased—Doxorubicin—ovarian cancer	0.00042	0.000751	CcSEcCtD
Calcitriol—Abdominal pain—Doxorubicin—ovarian cancer	0.00042	0.000751	CcSEcCtD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.00042	0.0018	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—YAP1—ovarian cancer	0.000416	0.00178	CbGpPWpGaD
Calcitriol—Asthenia—Epirubicin—ovarian cancer	0.000412	0.000736	CcSEcCtD
Calcitriol—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.00041	0.00175	CbGpPWpGaD
Calcitriol—Pruritus—Epirubicin—ovarian cancer	0.000406	0.000726	CcSEcCtD
Calcitriol—VDR—Generic Transcription Pathway—ESR1—ovarian cancer	0.000403	0.00173	CbGpPWpGaD
Calcitriol—Diarrhoea—Epirubicin—ovarian cancer	0.000393	0.000702	CcSEcCtD
Calcitriol—Hypersensitivity—Doxorubicin—ovarian cancer	0.000391	0.0007	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—YAP1—ovarian cancer	0.000386	0.00165	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000382	0.00164	CbGpPWpGaD
Calcitriol—Asthenia—Doxorubicin—ovarian cancer	0.000381	0.000681	CcSEcCtD
Calcitriol—Pruritus—Doxorubicin—ovarian cancer	0.000376	0.000672	CcSEcCtD
Calcitriol—Vomiting—Epirubicin—ovarian cancer	0.000365	0.000653	CcSEcCtD
Calcitriol—VDR—Gene Expression—PGR—ovarian cancer	0.000363	0.00156	CbGpPWpGaD
Calcitriol—Diarrhoea—Doxorubicin—ovarian cancer	0.000363	0.00065	CcSEcCtD
Calcitriol—Rash—Epirubicin—ovarian cancer	0.000362	0.000647	CcSEcCtD
Calcitriol—Dermatitis—Epirubicin—ovarian cancer	0.000361	0.000647	CcSEcCtD
Calcitriol—Headache—Epirubicin—ovarian cancer	0.000359	0.000643	CcSEcCtD
Calcitriol—GC—Metabolism—CAV1—ovarian cancer	0.00035	0.0015	CbGpPWpGaD
Calcitriol—Nausea—Epirubicin—ovarian cancer	0.000341	0.00061	CcSEcCtD
Calcitriol—VDR—Gene Expression—PARP1—ovarian cancer	0.000338	0.00145	CbGpPWpGaD
Calcitriol—Vomiting—Doxorubicin—ovarian cancer	0.000338	0.000604	CcSEcCtD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000336	0.00144	CbGpPWpGaD
Calcitriol—Rash—Doxorubicin—ovarian cancer	0.000335	0.000599	CcSEcCtD
Calcitriol—Dermatitis—Doxorubicin—ovarian cancer	0.000334	0.000598	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	0.000334	0.00143	CbGpPWpGaD
Calcitriol—Headache—Doxorubicin—ovarian cancer	0.000333	0.000595	CcSEcCtD
Calcitriol—GC—Metabolism—PIK3CG—ovarian cancer	0.000319	0.00137	CbGpPWpGaD
Calcitriol—Nausea—Doxorubicin—ovarian cancer	0.000315	0.000564	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—FASN—ovarian cancer	0.000315	0.00135	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—SLC5A5—ovarian cancer	0.00031	0.00133	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—SLC2A1—ovarian cancer	0.000299	0.00128	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000293	0.00125	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—CYP1B1—ovarian cancer	0.000287	0.00123	CbGpPWpGaD
Calcitriol—GC—Metabolism—PIK3CD—ovarian cancer	0.00028	0.0012	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—PPP2R1A—ovarian cancer	0.000274	0.00117	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PPP2R1A—ovarian cancer	0.000254	0.00109	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.000253	0.00108	CbGpPWpGaD
Calcitriol—GC—Metabolism—PIK3CB—ovarian cancer	0.000244	0.00105	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—ABCB1—ovarian cancer	0.000236	0.00101	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—TYMS—ovarian cancer	0.000232	0.000993	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	0.000218	0.000932	CbGpPWpGaD
Calcitriol—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000215	0.000919	CbGpPWpGaD
Calcitriol—GC—Metabolism—PTEN—ovarian cancer	0.000211	0.000904	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—MYC—ovarian cancer	0.00021	0.000898	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—ESR1—ovarian cancer	0.000194	0.000831	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—CAV1—ovarian cancer	0.000187	0.0008	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	0.000179	0.000765	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PIK3CG—ovarian cancer	0.00017	0.000729	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PIK3CD—ovarian cancer	0.00015	0.000641	CbGpPWpGaD
Calcitriol—GC—Metabolism—PIK3CA—ovarian cancer	0.000149	0.000638	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—NME2—ovarian cancer	0.000133	0.000568	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PIK3CB—ovarian cancer	0.00013	0.000559	CbGpPWpGaD
Calcitriol—GC—Metabolism—AKT1—ovarian cancer	0.000122	0.000521	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PTEN—ovarian cancer	0.000113	0.000483	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—MAPK3—ovarian cancer	0.000104	0.000445	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—MYC—ovarian cancer	0.000101	0.000432	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—CYTB—ovarian cancer	8.55e-05	0.000366	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PIK3CA—ovarian cancer	7.95e-05	0.000341	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—BRIP1—ovarian cancer	7.47e-05	0.00032	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PPP1CC—ovarian cancer	7.47e-05	0.00032	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—AKT1—ovarian cancer	7e-05	0.0003	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—AKT1—ovarian cancer	6.5e-05	0.000278	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—YAP1—ovarian cancer	5.01e-05	0.000215	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—FASN—ovarian cancer	4.09e-05	0.000175	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—SLC5A5—ovarian cancer	4.02e-05	0.000172	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—SLC2A1—ovarian cancer	3.88e-05	0.000166	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—CYP1B1—ovarian cancer	3.72e-05	0.000159	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	3.3e-05	0.000141	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—ABCB1—ovarian cancer	3.06e-05	0.000131	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—TYMS—ovarian cancer	3.01e-05	0.000129	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—CAV1—ovarian cancer	2.43e-05	0.000104	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.21e-05	9.46e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.94e-05	8.32e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.69e-05	7.25e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PTEN—ovarian cancer	1.46e-05	6.26e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.03e-05	4.42e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—AKT1—ovarian cancer	8.43e-06	3.61e-05	CbGpPWpGaD
